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1. Introduction 
Chlamydia are Gram negative obligate intracellular bacteria of eukaryotic cells and have a 
unique developmental cycle consisting of formation of infectious particle called elementary 
body and non-infectious particle called reticulate body. They are included in the order 
Chlamydiales and the order Chlamydiales belongs to the class Chlamydiae, phylum Chlamydiae, 
domain bacteria. The genus Chlamydia consists of important species C. muridarum, (affects 
only mice and hamsters) C. suis (affects only swine) and C. trachomatis (a human pathogen). 
Chlamydia are Gram-negative obligate intracellular eubacteria. Originally, they were 
taxonomically categorized into their own order Chlamydiales, with one family, Chlamydiaceae, 
and a single genus, Chlamydia.1 The genus included four species: C. trachomatis, C. psittaci ,C. 
pneumoniae and C. pecorum .In 1999, it was proposed by Everett et al 2 that Chlamydia should 
be  divided in two genera, Chlamydia and Chlamydophila, containing altogether nine species 
(Table 1) in addition to the five new species and three new families (Parachlamydiaceae,  
 
Species Host Route of entry 
CHLAMYDIA 
Chlamydia trachomatis Humans Pharyngeal, ocular, genital, 
rectal 
Chlamydia suis Pigs Pharyngeal 
Chlamydia muridarum Mouse, hamster Pharyngeal, genital 
CHLAMYDOPHILA 
Chlamydophila abortus Mammals Oral, genital 
Chlamydophila caviae Guinea pig Pharyngeal, ocular, genital, 
urethral 
Chlamydophila felis Cats Pharyngeal, ocular, genital 
Chlamydophila pecorum Mammals Oral 
Chlamydophila pneumoniae Humans ,frog, koala, 
horse 
Pharyngeal, ocular 
Chlamydophila psittaci Birds Pharyngeal, ocular, genital 
Table 1. The family Chlamydiaceae as proposed by Everett et al (1999) 
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Simniaceae and Waddliaceae).The molecular characteristics distinguishing Chlamydia and 
Chlamydiales is shown in Table 2. However, the proposal to change the taxonomic 
nomenclature for the Chlamyadiaceae family has not been generally accepted in the field. 3 
Two of the species, C. trachomatis and C. pneumoniae, are common pathogens in humans, 
whereas the other species occur mainly in animals.  
 
Genus 
Approximate 
Genome Size 
(million DNA base 
pairs) 
Detectable 
Glycogen 
Number of 
Ribosomal 
Operons 
Chlamydophila 1.2 Absent 1 
Chlamydia 1.0 Present 2 
Table 2. Molecular Criteria Distinguishing Chlamydiaceae  
2. Life cycle  
Chlamydia trachomatis exhibits an affinity for the epithelial cells of mucous membranes such 
as those found on the surfaces of the cervix, urethra, rectum, nasopharynx and conjunctiva, 
and enter these cells by a phagocytic process. 4 Within infected cells, Chlamydiae occur in 
intra cytoplasmic vesicles, or inclusion bodies. Within these inclusion bodies, morphological 
development takes place and two distinct particles are observed: a small, dense infective 
particle, the elementary body which is transformed in the host cell into the larger less dense 
form, the reticulate body. These non-infective but metabolically active reticulate bodies 
synthesize proteins and their own DNA and RNA, then replicate by binary fission to form 
micro colonies within the inclusion bodies. Between 18-24 hours post infection, the reticulate 
bodies divide and then ultimately some of the reticulate bodies reorganize into large 
numbers of elementary bodies. Between 48 and 72 hours post infection, the host cells 
ruptures releasing elementary bodies which can infect new host cells.5 The life cycle of C. 
trachomatis is shown in Figure 1. The species of Chalmydia causing infections is shown in 
Table 3. 
 
Species of Chlamydia Serovars Infection caused by the serovars 
Chlamydia trachomatis 
A, B ,Ba, C Blinding trachoma 
D - K 
Genital infections and infant pneumonia, 
Inclusion conjunctivitis 
L1,L2,L3 Lymphogranuloma venereum (LGV) 
Chlamyophila psitacii - Psittacosis 
Chlamydophila pneumoniae - Acute respiratory disease 
Table 3. Chalmydia causing different infections 
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Fig. 1. Life Cycle of Chlamydia 
3. Clinical manifestations 
C. trachomatis causes trachoma, infant pneumonia, LGV and nongonococcal urethritis. 
Although most infections caused by C. trachomatis in women are asymptomatic, clinical 
manifestations include cervicitis, urethritis, endometritis, Pelvic Inflammatory Disease (PID) 
or abscess of the Bartholin glands.6 Although the initial site of infection is usually the cervix, 
the urethra and rectum may also be infected. 7 The prevalence of C. trachomatis infection in 
pregnant women ranges from 2 to 35%.8 Pregnant women with chlamydial infections are at 
increased risk for adverse outcomes of pregnancy, and postpartum PID.  
C. trachomatis is the most common cause of neonatal conjunctivitis and pneumonia in early 
infancy .9 Fifteen to 25% of treated infants who were exposed at birth develop conjunctivitis, 
and 3 to 16% develop pneumonia . Symptoms of conjunctivitis usually develop within 2 
weeks of delivery, and if the infection is untreated, chlamydial pneumonia can develop at 4 
to 17 weeks after delivery .10 These conditions are occasionally difficult to treat, and prolonged 
hospitalization may be necessary . Infants with chlamydial pneumonia are at increased risk for 
later pulmonary dysfunction and possibly for chronic respiratory disease .11 
Trachoma. Endemic trachoma is a chronic disease caused by repeated infections of the 
conjunctiva and cornea by C. trachomatis. Trachoma is probably the most common cause of 
preventable blindness worldwide. Epidemiologic studies of trachoma in developing 
countries have shown that this disease is most often due to infection by C. trachomatis 
serotypes A to C. Scarring of the conjunctiva with resultant trauma to the cornea appears to 
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be due to repeated exposure to the chlamydial agent, which is transmitted primarily by 
nonsexual mechanisms. The ability to identify C. trachomatis from the conjunctivae of 
trachoma patients may vary greatly depending on the duration and clinical stage of the 
disease.12 
Lymphogranuloma venereum (LGV) LGV is a systemic disease caused by C. trachomatis 
serovars L1 to L3. The LGV serovars of C.trachomatis are more invasive than other genital 
serovars, resulting in infection of the epithelial layers and underlying soft tissue.13 The 
primary symptom is a painless genital ulcer or papule. The most common manifestation of 
the secondary stage of LGV in men, and the reason most men seek treatment, is 
inflammation and swelling of the inguinal lymph nodes .Women tend to be less 
symptomatic at this stage: only 20 to 30% of women present with inguinal 
lymphadenopathy and approximately one-third of women without proctocolitis present 
with lower abdominal and back pain.14 The secondary stage of infection is characterized by 
systemic symptoms including fever, malaise, chills, anorexia, myalgia, and arthralgia .15 
Untreated infections can lead to late complications including ulceration and hypertrophy of 
the genitalia, arthritis, and fistula formation involving the rectum, bladder, vagina, or 
vulva .14 
Nongonococcal urethritis. C. trachomatis serotypes D to K are the organisms most frequently 
associated with nongonococcal urethritis in men As many as one-third of men who harbor 
urethral Chlamydia may be asymptomatic In 1 to 2% of chlamydial urethral infections, 
infection can evolve to epididymitis. C. trachomatis is the most commonly isolated 
microorganism in young heterosexual men with epididymitis in whom there is no structural 
abnormality of the genitourinary disease. C. trachomatis infects the endocervix of women 
and may cause mucopurulent cervicitis.8 
This infection frequently spreads to the urethra and urinary bladder and may result in the 
"acute urethral syndrome"of abacteriuric pyuria .12 
Pneumonia  Pneumonia and bronchitis are the most frequently recognized illnesses 
associated with C. pneumoniae, although asymptomatic infection or unrecognized, mildly 
symptomatic illnesses are the most common result of infection. In a series of studies 10% of 
cases of pneumonia and approximately 5% of bronchitis and sinusitis cases in adults have 
been attributed to the organism 16.No set of symptoms or signs is unique to pulmonary 
infections with C. pneumoniae; however, several characteristics of the clinical presentation 
may help distinguish it from other causes .17 A subacute onset is common. Pharyngitis, 
sometimes with hoarseness, is often present early in the course of the illness. There may be a 
biphasic pattern to the illness, with resolution of pharyngitis prior to development of a more 
typical bronchitis or pneumonia syndrome. Cough is very common and is often 
prolonged.18,19 
Psittacosis. Reiter’s classic description of respiratory disease associated with avian 
exposure (ornithosis, formerly "psittacosis") was the first modern recognition of C. psittaci 
disease . Both psittacine and nonpsittacine birds can harbor the infectious agent, and 
avian C. psittaci strains cause illness in bird handlers and poultry workers. Because of the 
antigenic diversity of C. psittaci, serologic methods based on detection of antibody 
responses to genus-specific antigens of chlamydiae are used for the presumptive 
diagnosis of ornithosis. Although C. psittaci can be isolated in cell culture or by animal 
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inoculation with clinical specimens, the low sensitivity of these methods and the 
biohazard of C. psittaci in the laboratory  have made serologic diagnosis the indicated 
laboratory method for diagnosis of ornithosis. 
Mammalian. In spite of the broad range of non human hosts, zoonotic C. psittaci strains 
other than avian strains have infrequently been reported to cause human infection. A few 
cases of human infection resulting in abortion have been reported following infection by 
ovine C. psittaci strains .Rare cases of infective endocarditis presumed to be due to C. psittaci 
from avian and nonavian sources have also been reported. C. psittaci strains TWAR 
infections a novel group of chlamydial organisms has been associated with acute respiratory 
disease in humans. The acronym TWAR is derived from Taiwan-acute respiratory, the 
designations given to the first University of Washington studies that produced these strains. 
TWAR organisms have morphologic, antigenic, and developmental similarities to C. psittaci 
and are not inhibited in vitro by sulfonamides. Molecular studies of deoxyribonucleic acid 
relatedness suggest that TWAR agents are genetically homogeneous and differ from both C 
.psittaci and C. trachomatis. 20 
4. Epidemiology 
Although C. trachomatis infection did not become a fully reportable disease in the United 
States until 1996, it is known to be the most common bacterial sexually transmitted disease 
(STD). The actual incidence of chlamydial infection is not yet known due to lack of reporting 
in all 50 states up to 1996; however, national trends have been estimated by using data from 
states that reported cases prior to 1996, sentinel surveillance, surveys, and models based on 
proxies of infection .21,22 Worldwide, it is estimated that there are more than 50 million new 
cases of C. trachomatis infection annually.23 Although the major impact of disease caused by 
C. trachomatis is on the female reproductive tract, this agent also causes infections in men 
and children. 24 The prevalence of C. trachomatis infection in sexually active adolescent 
women, the population considered most at risk, generally exceeds 10%, and in some 
adolescent and STD clinic populations of women, the prevalence can reach 40%. 25 The 
prevalence of C.trachomatis infection ranges from 4 to 10% in asymptomatic men  and from 
15 to 20% in men attending STD clinics. 26, 27 Chlamydial infections in newborns occur as a 
result of perinatal exposure; approximately 65% of babies born from infected mothers 
become infected during vaginal delivery.28 
4.1 Clinical sequelae of C. trachomatis infections in infants 
C. trachomatis is the most common cause of neonatal conjunctivitis and one of the most 
common causes of pneumonia in early infancy. Prophylactic treatment of the eyes with 
silver nitrate does not prevent chlamydial infection; 15 to 25% of treated infants who were 
exposed at birth develop conjunctivitis, and 3 to 16% develop pneumonia.29 Symptoms of 
conjunctivitis usually develop within 2 weeks of delivery and if the infection is untreated, 
chlamydial pneumonia can develop at 4 to 17 weeks after delivery. These conditions are 
occasionally difficult to treat, and prolonged hospitalization may be necessary. Infants with 
chlamydial pneumonia are at increased risk to develop pulmonary dysfunction and possibly 
chronic respiratory disease.30 
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4.2 Clinical sequelae of C. trachomatis infections in men 
Among heterosexual men, chlamydial infections are usually urethral and up to 50% are 
asymptomatic 31. When symptoms do occur, usually 1 to 3 weeks following exposure, they 
are indistinguishable from those of gonorrhea (urethral discharge and/or pyuria). However, 
compared with gonococcal urethritis, chlamydial urethritis is more likely to be 
asymptomatic. In older men, epididymitis is more often due to other etiologies associated 
with urinary tract abnormalities or instrumentation rather than sexually transmitted 
origins.32 Unilateral scrotal pain is the primary symptom, and common clinical signs of this 
infection include scrotal swelling, tenderness, and fever. If urethral symptoms are also 
present, a sexually transmitted bacterial etiology is likely .33 
4.3 Reitter’s syndrome 
Reitter’s syndrome is caused by Chlamydia trachomatis The manifestations of reactive 
arthritis include the following triad of symptoms: an inflammatory arthritis of large joints 
including commonly the knee and the back (due to involvement of the sacroiliac joint), 
inflammation of the eyes in the form of conjunctivitis or uveitis, and urethritis in men or 
cervicitis in women. Patients can also present with mucocutaneous lesions, as well as 
psoriasis-like skin lesions such as circinate balanitis, and keratoderma blennorrhagica. Not 
all affected persons have all the manifestations, and the formal definition of the disease is 
the occurrence of otherwise unexplained non-infectious inflammatory arthritis combined 
with urethritis in men, or cervicitis in women.34 Symptoms generally appear within 1–3 
weeks but can range from 4 to 35 days from the onset of the inciting episode of the disease. 
The classical presentation is that the first symptom experienced is a urinary symptom such 
as burning pain on urination (dysuria) or an increased frequency of urination. Other 
urogenital problems may arise such as prostatitis in men and cervicitis, salpingitis and/or 
vulvovaginitis in women. 35 The arthritis that follows usually affects the large joints such as 
the knees causing pain and swelling with relative sparing of small joints such as the wrist 
and hand. Eye involvement occurs in about 50% of men with urogenital reactive arthritis 
and about 75% of men with enteric reactive arthritis. Conjunctivitis and uveitis can include 
redness of the eyes, eye pain and irritation, or blurred vision. 36 
4.4 Laboratory diagnosis of chlamydial infections 
Specimens used for detecting Chlamydiae must be handled cautiously following universal 
precautions. Handling of specimens for the detection of C. psittaci requires type III 
containment facility. The organism is air-borne and is highly virulent. 20  The most common 
anatomic site used to obtain specimens for the isolation of C. trachomatis from women is the 
endocervix, which is sampled with a swab (endocervix, Dacron and calcium alginate) or 
cytologic brush. The swab should be inserted into the cervical os past the squamocolumnar 
junction, about 1 to 2 cm deep, rotated for 15 to 30 s, and removed without touching the 
vaginal mucosa. 13 The transport medium may contain fetal calf serum up to 10% to 
preserve the viability of the organisms. The transport media may contain gentamycin or 
vancomycin , nystatin/ amphotericin B at a concentration of 10 microgram /ml  to prevent  
the growth of other bacteria and fungi respectively while transport. Specimen upon receipt 
in the laboratory should be processed as early as possible.  In case of delay the specimen can 
be stored for a maximum period of 48 hours in the refrigerator. If further delay is expected 
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the specimen should be stored at -700C until further processed. 37,38 The earlier methods used 
for the direct detection include iodine staining which stains the glycogen present in the cell 
lines. Giemsa staining is applied to detect the inclusion bodies of the organism. Later 
mononclonal antibodies raised against the major outer membrane protein gene of the 
organism tagged with a Fluorecein Iso thiocyanate (FITC) dye. was widely used for the 
rapid detection of the agent from direct clinical specimens.39  
4.5 Cultivation  
Until recently, culture was considered the gold standard for detection of Chlamydia in 
specimens because it has a specificity that approaches 100% . The usual cell lines in use are 
HeLa 229, L434 mouse fibroblasts or McCoy cells in the case of C. trachomatis and C. psittaci; 
Buffalo green monkey kidney cells for  C. psittaci and C. pecorum , HeLa or Hep2 cells for C. 
pneumoniae. The disadvantages of using culture as a gold standard include its relative 
insensitivity  compared with  DNA amplification techniques. 40 With the exception of 'fast 
growing' strains like the LGV biovar of C. trachomatis, it was usually necessary to assist the 
process of infection by centrifugation of the clinical material onto monolayers of the 
appropriate cells in tissue culture. Growth of the organisms was also facilitated by the use of 
anti-metabolites directed against the host cell (cycloheximide; emetine or mitomycin C) or, 
for the C. trachomatis TRIC: Trcahoma Inclusion conjunctivitis biovar, by the use of charged 
anionic polymers such as Poly - L - lysine or DEAE dextran. Compounds like polyethylene 
glycol or high energy glucose 6 phosphate also aided the growth of some chlamydiae. 41 
4.6 Rapid shell vial technique for cultivation  
Modified culture technique where the cells are grown over cover slips placed inside a glass 
shell vial is used for the rapid cultivation of Chlamydia. Here the cells are grown over the  
 
Fig. 2. Immunofluorescence staining showing Reticulate and Elementary bodies of 
Chlamydia trachomatis isolated from a case of ophthalmia neonatorum in McCoy cell culture 
(40 X) 
www.intechopen.com
 
Chlamydia 122 
cover slips and treated with cycloheximide (1microgram/ml) containing medium for 24 hours. 
42After the medium is aspirated out 200 micro liters of clinical specimen is added and the 
culture is centrifuged centrifuged at 3000 rpm  for 1 hour. At the end of 1 hour, Dulbecco’s 
minium essential medium with 10% fetal calf serum and 1-3 microgram cycloheximide is 
added and incubated at 37 OC  (10 % CO2 atmosphere) for 48-72 hours. At the end of 
incubation period the medium is aspirated out, the cover slip is fixed and stained with the 
antisera (Figure 2). This method is rapid and more sensitive in isolation of Chlamyida. 43  
Since susceptibility of a cell line is an important factor for cultivation of C. trachomatis, 
Malathi et al 44 have compared McCoy, HeLa, BHK-21, HEp-2, Vero and A549 cell lines for 
growth characteristics of C. trachomatis. These were inoculated with 150 infection-forming 
units (IFU) of C. trachomatis A, B, Ba and C serovars. Growth was graded according to the 
number of IFUs per microscopic field (100X). A549-cell line was not susceptible to infection 
by any of the serovars. The growth of C. trachomatis was good to very good in McCoy and 
HeLa cell lines. Vero, BHK-21 and HEp-2 cell lines varied considerably in the susceptibility 
to infection.44 
4.7 Polymerase chain reaction (PCR) and Ligase chain reaction (LCR)  
Plasmids of Chlamydia are known to exist in 7 copy numbers. Due to the rapidity, increased 
sensitivity and specificity PCR, LCR methods have widely replaced the conventional culture 
methods. 42,43  The major target for amplification based tests against C. trachomatis are 
generally multiple-copy gene products, such as the cryptic chlamydial plasmid (Figure 3) or 
ribosomal  RNA, Major outer membrane protein gene. Starting with a multiple copy gene 
offers a clear starting advantage with respect to sensitivity. The application of initial nucleic 
acid amplification based tests had increased the clinical sensitivity of detection of 
chlamydial DNA in clinical samples. 42,45  The major advantage of nucleic acid based 
amplification technique is the combined sensitivity and specificity. Automation is possible 
and a large volume of sample can be handled at a time. The technique was helpful to 
establish the etiology of the C. pneumoniae in optic neuritis46 where cultivation of the 
organism was not possible  
 
Fig. 3. Agarose electrophoretogam showing the MOMP amplified products of C. trachomatis 
from conjunctival swabs 
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5. Screening tests for chlamydia 
C. trachomatis infection is asymptomatic in 80% of women making diagnosis and 
detection difficult. Chlamydia has its high prevalence amongst young men and women 
and more than 13.5% of women < 25 years old have lower genital tract infections.47 
Screening women for lower genital tract infection with C. trachomatis is important in the 
prevention of PID, ectopic pregnancy and infertility.48 The screening tests available for C. 
trachomatis include nucleic acid based amplification assays, PCR and LCR, gene probe 
and enzyme immuno assay. The sensitivity and specificity of Chlamydia trachomatis 
screening tests is provided in Table 4. 
 
Test Sensitivity Specificity Detection limit 
(no of organisms) 
NAATa 90-95 >99 1-10 
DFAb 80-85 >99 10-500 
EIAc 60-85 99 500-1000 
DNA Probed 75-85 > 99 500 -1000 
Cell culture 50-85 100 5-100 
POCe 20-55 >90 >10,000 
NOTE: 
a DNA based amplicor assay  (Roche diagnostic, Basel Switzerland), LCR (Abbott Lab, Abbott Park 
IL, USA) 
b DFA Expansion: Direct fluorescence assay – Syva MicroTrak (Syva Co, Palo, Alto, CA, USA) 
c EIA – Vidas (BioMerieux, Craporre France) 
d DNA probe based hybrid capture assay (QIAGEN, Hilden Germany), Ampliprobe system (Imclone 
systems, NY, USA) RNA Based (Gen probe San Diego CA, USA) 
e Point of care test : Handilab C (Zonda incorporated Dallas TX, USA), Biorapid Chlamydia antigen test 
(Biokit, Barcelona, Spain) Quick Vue Chlamydia test (Quidel Corporation, San Diego CA, USA) 
Table 4. Sensitivity and specificity of Chlamydia trachomatis  detection assays and most 
widely used commercially available tests 49 
Screening programmes are promoted to control transmission and prevention of female 
reproductive tract morbidity caused by genital Chlamydia. Offering an annual screening test 
to men and women aged under 20 years may be the  most cost effective strategy if PID 
progression is 10% or higher. Screening is essential to reduce the propagation of the disease. 
Annual testing is recommended for women at high risk for Chlamydial infection. According 
to Centre for Disease Control (CDC), the following patients population should be screened 
for Chlamydia infection. 
 Sexually active female adolescents 
 Women undergoing induced abortion 
 Women attending STD clinic 
 Women with mucopurulent cervicitis 
 Women with new / multiple sexual partners within 3 months of presentation50 
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5.1 Chlamydial infection in chronic ill patients 
C. pneumoniae infection can cause acute respiratory illnesses (including sinusitis, 
bronchitis, and pneumonia) that are sometimes associated with wheezing. Little is known 
about whether acute infection in a previously unexposed, non asthmatic individual can 
produce persistent wheezing leading to a diagnosis of chronic asthma. Hahn et al 51 
conducted a study on  163 primary outpatient adults (average age 43, 45% male) who had 
acute wheezing illnesses or chronic asthma to evaluate C. pneumoniae infection by 
serologic testing. C. pneumoniae infection was diagnosed if the organism was detected one 
or more times by culture, or if a patient met accepted serologic criteria for acute infection: 
an IgM antibody titer of 1:16 or greater, a fourfold or greater rise in IgM, IgG or total Ig 
titer between acute and convalescent sera, or a single IgG or total Ig titer of 1:512 or 
greater.11 Criteria for an acute primary (first exposure) C. pneumoniae infection include the 
presence of IgM antibody in a titer of 1:16 or greater whereas IgM is absent in acute 
secondary infection (re-exposure).In the setting of acute bronchitis or pneumonia, a single 
IgG titer of 1:512 or greater correlates with organism identification and is also indicative 
of acute infection. 
Acute C. pneumoniae respiratory tract infections in previously unexposed, non asthmatic 
individuals can result in chronic asthma. Patients previously diagnosed with chronic asthma 
should be evaluated for possible chronic C. pneumoniae infection. 
5.2 Chlamydial infections in pregnancy 
Prematurity is one of the leading causes of perinatal mortality. Uterine contractions may be 
induced by cytokines, proteolytic enzymes or prostaglandins released or induced by 
microorganisms.  Some studies 52,53 suggest that maternal C. trachomatis infection in 
pregnancy is associated with premature delivery.  Termination of pregnancy (i.e. induced 
abortion) is one of the most commonly performed gynecological procedures. Post-abortal 
PID is a well recognized complication of termination of pregnancy, with its attendant risks 
of tubal dysfunction and either infertility or subsequent ectopic pregnancy.  
6. Prevention 
Chlamydia prevention programs have been implemented to reduce the burden of 
reproductive sequelae resulting from chlamydial infection. Because most reproductive 
complications of Chlamydia occur in females and most infections are asymptomatic, the 
cornerstone of Chlamydia prevention is screening young females for infection. Nucleic acid 
amplification tests are the preferred diagnostic tests because of their superior sensitivity, 
and they can be performed on easily collected specimens, such as urine or vaginal swabs.53 
Highly efficacious treatment options include single-dose oral azithromycin or a 1-week 
course of doxycycline. National chlamydia screening recommendations were first released 
in 1993. Currently, CDC, the U.S. Preventive Services Task Force (USPSTF), and numerous 
professional medical associations recommend annual chlamydia screening for all sexually 
active females aged < 25 years and for females aged ≥ 25 years if they are at increased risk 
for infection (e.g., if they have new or multiple sex partners.54 
C. pneumoniae is difficult to prevent because it is spread by respiratory droplets from other 
sick people.Because people with this type of pneumonia do not always feel very sick, they 
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often continue to attend school, go to work, and go to other public places. They then spread 
the bacteria in the tiny droplets that are released into the air during coughing. Therefore, 
this pneumonia is very difficult to prevent and often occurs in outbreaks within 
communities.20 Prevention of C. trachomatis pneumonia involves recognizing the symptoms 
of genital infection in the mother and treating her prior to delivery of her baby.53 
6.1 Prognosis of Chlamydia infection 
The 'prognosis' of Chlamydia usually refers to the likely outcome of Chlamydia. The prognosis 
of Chlamydial infection  may include the duration, chances of complications of Chlamydia 
infection , probable outcomes, prospects for recovery, recovery period for Chlamydia, 
survival rates, death rates, and other outcome possibilities in the overall prognosis of 
Chlamydia. Naturally, such forecast issues are by their nature unpredictable 
The following are statistics from various sources about deaths related to Chlamydia:  
Chlamydia death statistics for various regions worldwide:  
 About 1,000 deaths from Chlamydia in Africa 2002  
 About 8,000 deaths from Chlamydia in South East Asia 2002  
 About 1,000 deaths from Chlamydia in Eastern Mediterranean 200255   
 Treated with antibiotics, chlamydial infections can be cured 95% of the time.  
6.2 Chlamydial infection in children 
Exposure to C. trachomatis during delivery can cause ophthalmia neonatorum 
(conjunctivitis) in neonates or chlamydial pneumonia at one to three months of age. 
6.3 Ophthalmia neonatorum 
Ophthalmia neonatorum usually occurs within five to 12 days of birth but can develop at 
any time up to one month of age. It may cause swelling in one or both eyes with 
mucopurulent drainage. Prophylaxis with silver nitrate or antimicrobial ointment, which 
reduces the risk of gonococcal infection in neonates, does not reduce the risk of chlamydial 
infection. Testing for chlamydial infection in neonates can be done by culture or nonculture 
techniques. The eyelid should be everted and the sample obtained from the inner aspect of 
the eyelid. Sampling the exudates is not adequate because this technique increases the risk 
of a false-negative test. Ophthalmia neonatorum can be treated with erythromycin base or 
ethylsuccinate at a dosage of 50 mg per kg per day orally, divided into four doses per day 
for 14 days. The cure rate for both options is only 80 percent, so a second course of therapy 
may be necessary. Topical treatment is ineffective for ophthalmia neonatorum and should 
not be used even in conjunction with systemic treatment.53 
6.4 Chlamydial pneumonia 
Acute lower respiratory tract infection (ALRTI) is the major cause of morbidity and 
mortality in young children world wide.Chlamydia pneumoniae is a common respiratory 
pathogen which is responsible for about 10% of community acquired pneumonia (CAP). 
The best method of microbiological diagnosis at the acute stage of Chlamydial infection is 
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undecided, because the organism grows poorly on cell culture.20  Testing can be performed 
on a sample obtained from the nasopharynx. Nonculture techniques may be used, but they 
are less sensitive and specific for nasopharyngeal specimens than for ocular specimens. If 
tracheal aspirates or lung biopsies are being collected for pneumonia in infants one to three 
months of age, the samples should be tested for C. trachomatis. 
Like ophthalmia neonatorum, pneumonia secondary to C. trachomatis is treated with 
erythromycin base or ethylsuccinate at a dosage of 50 mg per kg per day orally, divided into 
four doses per day for 14 days. As with ophthalmic infection, a second course of therapy 
may be necessary.53 
7. Advanced research 
7.1 Polymorphisms associated with ocular and genital isolates of C. trachomatis 
Genome sequence of several diverse strains has revealed a remarkable level of genomic 
synteny suggesting that minor genetic differences determine the pathogen host and tissue 
specific infection characteristics. To better understand the genetic basis of Chalmydial 
pathobiologic diversity, Carlson et al 56 performed a comparative DNA –DNA microarray 
genomic hybridization and reported with all 15 Chlamydia trachomatis serovariants and 
reported only a few major genetic differences. An exception was the cytotoxin locus located 
in the plasticity zone, a region that exhibited significant polymorphisms among serovars. 
The cytotoxin gene was interrupted by extensive mutants and deletions among different 
serovars however 3 basic open reading frames (ORF) were discovered that correlated with 
non invasive genitotropic serovars which possess  an intact N terminal portion of the 
putative toxin gene. This region contains the UDP Glucose binding domain and the glycosyl 
transferase domain required for enzymatic activity of Clostridium toxin homologues 
suggesting a role in urogenital infection/ pathogenesis.57 
C. trachomatis exists as multiple serovariants that exhibit distinct organo tropism for the eye 
or urogenital tract. The genome of an oculotropic trachoma isolate (A/HAR-13) was 
sequenced and compared to the genome of a genitotropic (D/UW-3) isolate. Remarkably, 
the genomes share 99.6% identity, supporting the conclusion that a functional tryptophan 
synthase enzyme and toxin might be the principal virulence factors underlying disease 
organotropism. Tarp (translocated actin-recruiting phosphoprotein) was identified to have 
variable numbers of repeat units within the N and C portions of the protein. A correlation 
exists between lymphogranuloma venereum serovars and the number of N-terminal 
repeats. Single-nucleotide polymorphism (SNP) analysis between the two genomes 
highlighted the minimal genetic variation. A disproportionate number of SNPs were 
observed within some members of the polymorphic membrane protein (pmp) 
autotransporter gene family that corresponded to predicted T-cell epitopes that bind HLA 
class I and II alleles. These results implicate Pmps as novel immune targets, which could 
advance future chlamydial vaccine strategies. Lastly, a novel target CTA0934 for PCR 
diagnostics was discovered that can discriminate between ocular and genital strains. This 
discovery will enhance epidemiological investigations in nations where both trachoma and 
chlamydial STD are endemic. The results suggest that Tarp is among the few genes to play a 
role in adaptations to specific niches in the host.58 
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7.2 Chlamydial L,L – diaminopimelate aminotransferase 
Recent phylogenetic studies have revealed that chlamydia shares a common ancestor with 
modern plants and retains unusual plant-like traits (both genetically and physiologically). In 
particular, the enzyme L,L-diaminopimelate aminotransferase, which is related to lysine 
production in plants, is also linked with the construction of chlamydia's cell wall. The 
genetic encoding for the enzymes is remarkably similar in plants and chlamydia, 
demonstrating a close common ancestry.59 This unexpected discovery may help scientists 
develop new treatment avenues: if scientists could find a safe and effective inhibitor of L,L-
diaminopimelate aminotransferase, they might have a highly effective and extremely 
specific new antibiotic against chlamydia.        
7.3 Emerging Chlamydial infections 
Several Chlamydial like bacteria have recently been identified as potential emerging public 
threats or pathogenic agents in animals. Parachlamydia acanthamoebae, Parachalmydia 
naegelerophila and Simkania negerensis have been reported as possible aetiological agents of 
pneumonia in humans. To define further the possible pathogenetic potential of these 
Chlamydia like bacteria new diagnostic tools are needed to demonstrate the agent within 
tissue lesions.60 Borel et al 60 have used tissue microarray technology to establish the 
immuno histochemistry protocols and to determine the specificity of new antisera against 
various Chlamydia like bacteria for future use on formalin fixed and paraffin embedded 
tissues. The antisera exhibited strong reactivity against autologous antigen and closely 
related heterologous antigen but no cross reactivity with distantly related species. 
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